对于围产期抑郁症而言,艾斯基坦胺的有效性:系统性审查和元分析
Sabrina Wong1,2,3, Gia Han Le1,2,4, Angela T H Kwan1,5
1Brain and Cognition Discovery Foundation, Toronto, ON, Canada.
CNS spectrums
|October 31, 2024
概括
预防性乙胺显著降低了产后抑郁症 (PPD) 在分娩后一周内和4-6周内的发病率. 这一发现表明,胺可能为母亲提供预防性抗抑郁药的好处.
科学领域:
- 生殖精神病学是一种精神病学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 产后抑郁症 (PPD),现在被称为围产期抑郁症,是一种常见的情绪障碍,影响母亲的生活质量和功能.
- 埃斯凯特胺在治疗耐药性抑郁症中表现出有效性,并具有与分娩疼痛管理相关的止痛特性.
研究的目的:
- 评价esketamine在减少PPD发病率方面的预防性疗效.
- 综合PPD预防esketamine随机对照试验的证据.
主要方法:
- 来自PubMed,Scopus和Ovid数据库的随机对照试验的系统审查 (至2024年1月22日).
- 包括专门研究以PPD预防为首要结果的研究.
- 使用随机效应模型对PPD发病率的元分析.
主要成果:
- 七项研究符合元分析的资格标准.
- 乙胺与产后一周内PPD诊断的发生率降低显著相关 (OR = 0.30,p = 0.0047).
- 素还显著降低了产后4至6周的PPD发病率 (OR = 0.33,p = 0.0034).
结论:
- 埃斯凯特胺在产后期显示出潜在的预防性抗抑郁药物作用.
- 这些发现对PPD治疗策略有着重要的机制和临床影响.
相关概念视频
01:30Electroconvulsive Therapy
25
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
25
01:23Antidepressant Drugs: MAOIs and Other Agents
196
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
196